These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 16984497)

  • 1. Effect of a proton pump inhibitor on postprandial gastric volume, emptying and symptoms in healthy human subjects: a pilot study.
    Grudell AB; Camilleri M; Burton DD; Stephens DA
    Aliment Pharmacol Ther; 2006 Oct; 24(7):1037-43. PubMed ID: 16984497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of oral CCK-1 agonist GI181771X on fasting and postprandial gastric functions in healthy volunteers.
    Castillo EJ; Delgado-Aros S; Camilleri M; Burton D; Stephens D; O'Connor-Semmes R; Walker A; Shachoy-Clark A; Zinsmeister AR
    Am J Physiol Gastrointest Liver Physiol; 2004 Aug; 287(2):G363-9. PubMed ID: 15246968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity does not increase effects of synthetic ghrelin on human gastric motor functions.
    Cremonini F; Camilleri M; Vazquez Roque M; McKinzie S; Burton D; Baxter K; Zinsmeister AR
    Gastroenterology; 2006 Nov; 131(5):1431-9. PubMed ID: 17101319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind, randomized, placebo-controlled trial of itopride (100 and 200 mg three times daily) on gastric motor and sensory function in healthy volunteers.
    Choung RS; Talley NJ; Peterson J; Camilleri M; Burton D; Harmsen WS; Zinsmeister AR
    Neurogastroenterol Motil; 2007 Mar; 19(3):180-7. PubMed ID: 17300287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a cannabinoid agonist on gastrointestinal transit and postprandial satiation in healthy human subjects: a randomized, placebo-controlled study.
    Esfandyari T; Camilleri M; Ferber I; Burton D; Baxter K; Zinsmeister AR
    Neurogastroenterol Motil; 2006 Sep; 18(9):831-8. PubMed ID: 16918762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of somatostatin analog on postprandial satiation in obesity.
    Cremonini F; Camilleri M; Gonenne J; Stephens D; Oenning L; Baxter K; Foxx-Orenstein A; Burton D
    Obes Res; 2005 Sep; 13(9):1572-9. PubMed ID: 16222060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive measurement of gastric accommodation in patients with idiopathic nonulcer dyspepsia.
    Kim DY; Delgado-Aros S; Camilleri M; Samsom M; Murray JA; O'Connor MK; Brinkmann BH; Stephens DA; Lighvani SS; Burton DD
    Am J Gastroenterol; 2001 Nov; 96(11):3099-105. PubMed ID: 11721755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nizatidine improves clinical symptoms and gastric emptying in patients with functional dyspepsia accompanied by impaired gastric emptying.
    Futagami S; Shimpuku M; Song JM; Kodaka Y; Yamawaki H; Nagoya H; Shindo T; Kawagoe T; Horie A; Gudis K; Iwakiri K; Sakamoto C
    Digestion; 2012; 86(2):114-21. PubMed ID: 22846371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In functional dyspepsia, hypersensitivity to postprandial distention correlates with meal-related symptom severity.
    Farré R; Vanheel H; Vanuytsel T; Masaoka T; Törnblom H; Simrén M; Van Oudenhove L; Tack JF
    Gastroenterology; 2013 Sep; 145(3):566-73. PubMed ID: 23702005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of erythromycin on gastric emptying and meal related symptoms in functional dyspepsia with delayed gastric emptying.
    Arts J; Caenepeel P; Verbeke K; Tack J
    Gut; 2005 Apr; 54(4):455-60. PubMed ID: 15753526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of buspirone, a fundus-relaxing drug, in patients with functional dyspepsia.
    Tack J; Janssen P; Masaoka T; Farré R; Van Oudenhove L
    Clin Gastroenterol Hepatol; 2012 Nov; 10(11):1239-45. PubMed ID: 22813445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic efficacy of acotiamide in patients with functional dyspepsia based on enhanced postprandial gastric accommodation and emptying: randomized controlled study evaluation by real-time ultrasonography.
    Kusunoki H; Haruma K; Manabe N; Imamura H; Kamada T; Shiotani A; Hata J; Sugioka H; Saito Y; Kato H; Tack J
    Neurogastroenterol Motil; 2012 Jun; 24(6):540-5, e250-1. PubMed ID: 22385472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of 5-HT(3) antagonism on postprandial gastric volume and symptoms in humans.
    Kuo B; Camilleri M; Burton D; Viramontes B; McKinzie S; Thomforde G; O'Connor MK; Brinkmann BH
    Aliment Pharmacol Ther; 2002 Feb; 16(2):225-33. PubMed ID: 11860405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of gastric volume or emptying on meal-related symptoms after liquid nutrients in obesity: a pharmacologic study.
    Delgado-Aros S; Camilleri M; Castillo EJ; Cremonini F; Stephens D; Ferber I; Baxter K; Burton D; Zinsmeister AR
    Clin Gastroenterol Hepatol; 2005 Oct; 3(10):997-1006. PubMed ID: 16234046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of ghrelin on the gastric accommodation reflex and on meal-induced satiety in man.
    Ang D; Nicolai H; Vos R; Mimidis K; Akyuz F; Kindt S; Vanden Berghe P; Sifrim D; Depoortere I; Peeters T; Tack J
    Neurogastroenterol Motil; 2009 May; 21(5):528-33, e8-9. PubMed ID: 19210631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastric sensory and motor dysfunction in adolescents with functional dyspepsia.
    Chitkara DK; Camilleri M; Zinsmeister AR; Burton D; El-Youssef M; Freese D; Walker L; Stephens D
    J Pediatr; 2005 Apr; 146(4):500-5. PubMed ID: 15812453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of ghrelin on gastric emptying and meal-related symptoms in idiopathic gastroparesis.
    Tack J; Depoortere I; Bisschops R; Verbeke K; Janssens J; Peeters T
    Aliment Pharmacol Ther; 2005 Nov; 22(9):847-53. PubMed ID: 16225494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of GLP-1 on gastric volume, emptying, maximum volume ingested, and postprandial symptoms in humans.
    Delgado-Aros S; Kim DY; Burton DD; Thomforde GM; Stephens D; Brinkmann BH; Vella A; Camilleri M
    Am J Physiol Gastrointest Liver Physiol; 2002 Mar; 282(3):G424-31. PubMed ID: 11841992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secretin effects on gastric functions, hormones and symptoms in functional dyspepsia and health: randomized crossover trial.
    Brandler J; Miller LJ; Wang XJ; Burton D; Busciglio I; Arndt K; Harmsen WS; Camilleri M
    Am J Physiol Gastrointest Liver Physiol; 2020 Apr; 318(4):G635-G645. PubMed ID: 32036693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of NK1 receptors on gastric motor functions and satiation in healthy humans: results from a controlled trial with the NK1 antagonist aprepitant.
    Jacob D; Busciglio I; Burton D; Halawi H; Oduyebo I; Rhoten D; Ryks M; Harmsen WS; Camilleri M
    Am J Physiol Gastrointest Liver Physiol; 2017 Nov; 313(5):G505-G510. PubMed ID: 28814387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.